If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
Department of Diagnostic and Therapeutic Radiology, Kawasaki Medical School General Medical Centre, 2-6-2 Nakasange, Kita-ku, Okayama City, Okayama, 700-8505, Japan
Department of Diagnostic and Therapeutic Radiology, Kawasaki Medical School General Medical Centre, 2-6-2 Nakasange, Kita-ku, Okayama City, Okayama, 700-8505, Japan
Department of Diagnostic and Therapeutic Radiology, Kawasaki Medical School General Medical Centre, 2-6-2 Nakasange, Kita-ku, Okayama City, Okayama, 700-8505, Japan
Department of Diagnostic and Therapeutic Radiology, Kawasaki Medical School General Medical Centre, 2-6-2 Nakasange, Kita-ku, Okayama City, Okayama, 700-8505, Japan
Department of Obstetrics and Gynecology 2, Kawasaki Medical School General Medical Centre, 2-6-2 Nakasange, Kita-ku, Okayama City, Okayama, 700-8505, Japan
Department of Obstetrics and Gynecology 2, Kawasaki Medical School General Medical Centre, 2-6-2 Nakasange, Kita-ku, Okayama City, Okayama, 700-8505, Japan
Uterine myxoid leiomyosarcomas (MLMSs) are extremely rare. Here, we report a rare case of uterine MLMS with unique and bizarre magnetic resonance imaging (MRI) findings on diffusion-weighted images (DWIs) and dynamic contrast-enhanced (DCE) MRI scans. A 67-year-old woman presented with a uterine MLMS that had a multilocular cystic mass with a septum and solid components. The tumour demonstrated marked hyperintensity on T2-weighted images in a myxoid stroma with gradual partial contrast enhancement and diffusion restriction, which could be a characteristic feature suggestive of a myxoid malignant smooth muscle tumour of the uterus rather than a uterine leiomyoma with myxoid degeneration.
C. Parra-Herran, J.K. Schoolmeester, L. Yuan, P. Dal Cin, C.D.M. Fletcher, B.J. Quade, M.R. Nucci, Myxoid leiomyosarcoma of the uterus: A clinicopathologic analysis of 30 cases and review of the literature with reappraisal of its distinction from other uterine myxoid mesenchymal neoplasms, Am. J. Surg. Pathol. 40 (2016) 285–301. https://doi.org/10.1097/PAS.0000000000000593.
]. On magnetic resonance imaging (MRI), ULs with myxoid degeneration has a distinctive appearance with markedly high signal intensity (SI) on T2-weighted images (T2WIs) and enhanced well except for small foci of mucinous lakes or clefts. Delayed and prolonged enhancement can be observed because of the presence of a myxoid stroma [
]. In the literature, to the best of our knowledge, reported MRI features of uterine MLMS have been limited to two cases with T2WIs and contrast-enhanced T1-weighted images (T1WIs) [
]. Therefore, MRI features of uterine MLMS have not been completely investigated; in particular, features on diffusion-weighted images (DWIs) and dynamic contrast-enhanced (DCE) MRI scans have not been reported in patients with uterine MLMS. Herein, we report a rare case of uterine MLMS that had unique and bizarre MRI findings on DWIs and DCE MRI. We also present a brief a literature review.
2. Case presentation
A 67-year-old woman was referred to our radiology department for the examination and further assessment of a pelvic mass detected using ultrasonography. The patient had complained of fatigue and nausea since 1 week before presenting to the hospital. Physical examination revealed slight tenderness in the lower abdomen. Laboratory data and tumour markers, including carbohydrate antigen (CA) 125, CA72-4, carcinoembryonic antigen, and CA19-9, were within normal limits.
MRI revealed a huge uterine mass measuring 175 mm × 99 mm × 127 mm and involving the uterine corpus almost entirely and the uterine cervix partially, as well as a small myoma in the posterior uterine wall without metastatic lesions (Fig. 1a). The tumour mainly had a markedly heterogeneous hyperintense area with hypointense reticular structures partially on T2WI (Fig. 1a, b). The tumour had a hypointense area and a slightly hyperintense area compared with that of the muscle on T1WIs (Fig. 1c), and no fat component was visible on fat-saturated T1WIs (Fig. 1d). On DCE MRI scans (Fig. 1e) and late contrast-enhanced T1WIs (Fig. 1f), the tumour had gradual and heterogeneous contrast enhancement in the low SI region on T2WIs corresponding to the septum and solid parts within the tumour and in parts of the high SI region on T2WIs corresponding to myxoid degeneration. These areas had slightly increased SI region on DWIs (Fig. 1g) and restriction of diffusion on apparent diffusion coefficient (ADC) maps (Fig. 1h) within the myxoid degeneration where contrast enhancement was observed. On the other hand, no contrast enhancement was observed in the central cystic parts of the high SI region on T2WIs with low SI and slightly high SI on T1WIs, which corresponded to myxoid degeneration with partially haemorrhagic necrosis. Based on the MRI findings, MLMS, myxoid leiomyoma (LM), and smooth muscle tumours of uncertain malignant potential were the preoperative differential diagnoses. However, distinguishing these tumours precisely based on MRI findings was challenging.
a)Sagittal T2-weighted images revealing a huge multilobulated uterine mass involving the uterine region almost entirely and a small myoma (repetition time [TR]/effective echo time [TE], 4802/81 ms). There are no signs of infiltration in adjacent structures.
b)Axial T2-weighted images showing a marked hyperintense mass with multiple hypointense septa (TR/TE, 4802/81 ms).
c)The hypointense mass had a slight partial hyperintense area (arrow) compared with that of muscle on axial T1-weighted MR images (TR/TE, 525/13.4 ms).
d)The hypointense mass had a slight partial hyperintense area (arrow) compared with that muscle on axial fat-saturated T1-weighted MR images (TR/TE, 500/12.9 ms).
e)Axial dynamic contrast-enhanced T1-weighted images showing initial heterogeneous enhancement with progressive filling-in at the septum, solid parts, and parts of the myxoid degeneration (TR/TE, 4.21/0.0 ms). Pre: precontrast; 1 st, 2nd, and 3rd: acquired at 35, 60, and 80 s after contrast material injection (CMI).
f)Late contrast-enhanced T1-weighted image with fat-saturation acquired at 2 min after CMI showing a more widespread heterogeneous marked contrast enhancement at the septum, solid parts within the tumour, and in parts of the myxoid degeneration (TR/TE, 594.8/14.2 ms).
g)Diffusion-weighted images showing high signal intensity within myxoid degeneration where contrast enhancement was observed and the septa, comparing the other parts of the tumour (TR/TE, 9000/65.7 ms, b-value = 800 s/mm2).
h)Lowest mean apparent diffusion coefficient value of the tumour was 1.17 × 10 − 3 mm2/s (TR/TE, 9000/65.7 ms, b-value = 800 s/mm2).
Tumour resection with total hysterectomy and bilateral oophorectomy was performed. On the cut section, the uterine tumour was an 18-cm-sized well-circumscribed tumour with a gelatinous surface. The tumour was composed of yellowish, partly dark red foci of haemorrhage, and gelatinous texture deposits separated by fibrous septum (Fig. 2). Microscopically, the spindle-shaped cells with ovoid or elongated nuclei and eosinophilic cytoplasm were arranged into irregular bundles or separated by myxoid stroma. The tumour invaded the neighbouring myometrium via vascular invasion. Mitotic figures were found at a rate of 2–5 per 10 high-power fields (Fig. 3a, b). Immunohistochemical analysis revealed tumour cells to be positive for calponin, α-smooth muscle actin, oestrogen receptor, p16, and CD10, and focally positive for desmin, S100 protein, and p53. Tumour cells were not immunoreactive for progesterone receptor, CD34, and ALK. MIB-1 immunostaining showed positive nuclear staining in approximately 26% of cells. These pathological findings resulted in the diagnosis of a myxoid leiomyosarcoma of the uterus.
Fig. 2Photograph of the cut surface of the uterine tumour.
a)A macrograph of the specimen shows the gelatinous portion consisted of degenerated mucin.
b)Microscopically, the spindle-shaped cells with ovoid or elongated nuclei and eosinophilic cytoplasm were arranged as irregular bundles or separated by myxoid stroma.
Uterine MLMS is a rare malignant counterpart of myxoid LM, which has been rarely reported in the literature. Despite its deceptively benign histologic appearance and a low mitotic count, uterine MLMS can metastasise, and unexpected malignant transformations of pre-existing ULs have been reported [
C. Parra-Herran, J.K. Schoolmeester, L. Yuan, P. Dal Cin, C.D.M. Fletcher, B.J. Quade, M.R. Nucci, Myxoid leiomyosarcoma of the uterus: A clinicopathologic analysis of 30 cases and review of the literature with reappraisal of its distinction from other uterine myxoid mesenchymal neoplasms, Am. J. Surg. Pathol. 40 (2016) 285–301. https://doi.org/10.1097/PAS.0000000000000593.
In a previous report, areas of myxoid degeneration within a UL showed heterogeneous and marked hyperintensity on T2WIs, with progressive enhancement developing after contrast administration except for small foci of mucinous lakes or clefts [
]. Regarding uterine MLMS, Holzmann et al. demonstrated that main parts of the large tumour had hyperintense cystic areas on T2WIs and the solid part with contrast enhancement was within the central part of the tumour [
]. In the present case, the uterine MLMS had the hyperintense regions on T2WIs, which corresponded to myxoid degeneration, with or without gradual and prolonged contrast enhancement, and the septum and solid parts showed hypointense signals on T2WIs with gradual contrast enhancement on DCE MRI scans. We suspected that the extent of the vascular network within myxoid degeneration in the UL and uterine MLMS was responsible for the difference in enhancement patterns in hyperintense regions on T2WIs as extraperitoneal soft tissue tumours with myxoid stroma [
]. However, there have been no published reports on uterine MLMS with DCE MRI findings, and typical and detailed enhancement patterns of uterine MLMS remain unclear.
DWIs shows tissue characteristics based on the diffusion motion of water molecules. In general, DWIs can delineate malignant lesions as a hyperintense area with excellent tissue contrast, and cases with hypointense signals on DWIs may be regarded as benign lesions in smooth muscle tumours of the uterus [
]. In contrast, previous studies have reported that there were overlaps in ADC values between a UL, such as cellular LM and bizarre LM, and uterine sarcoma, suggesting that DWIs alone are not sufficient to make a definite diagnosis [
Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.
]. A previous study reported a uterine LMS with an intermediate SI on DWI associated with mucous degeneration without any imaging feature of the case and revealed that uterine smooth muscle tumours with intermediate-to-high SI may indicate uterine leiomyosarcoma [
]. The present case revealed high SI on DWIs for myxoid stroma with contrast enhancement. The MRI findings in the present case suggest that DWIs and ADC values can be potentially useful for differentiating MLMS from myxoid LM, and this needs to be assessed in further research in the future.
In conclusion, typical imaging findings of uterine MLMS include a multilocular cystic appearance and tumour with markedly high SI on T2WIs with gradual enhancement on DCE MRI scans. High SI on DWIs may be a potential marker in differentiating myxoid LM from MLMS. Therefore, it is critical to consider the possibility of uterine MLMS when examining uterine cystic tumours with high SI on T2WIs with gradual enhancement on DCE MRI scans and high SI on DWIs.
4. Informed consent and patient details
This study does not require institutional review board approval. Informed consent was obtained for the case report to be published.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Declaration of Competing Interest
None of the authors have any relevant conflict of interest or industry support related to this report.
Acknowledgements
None.
Appendix A. Supplementary data
The following is Supplementary data to this article:
C. Parra-Herran, J.K. Schoolmeester, L. Yuan, P. Dal Cin, C.D.M. Fletcher, B.J. Quade, M.R. Nucci, Myxoid leiomyosarcoma of the uterus: A clinicopathologic analysis of 30 cases and review of the literature with reappraisal of its distinction from other uterine myxoid mesenchymal neoplasms, Am. J. Surg. Pathol. 40 (2016) 285–301. https://doi.org/10.1097/PAS.0000000000000593.
Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.
00008-3&id=gr1.jpg){kind=link}
00008-3&id=gr2.jpg){kind=link}
00008-3&id=gr3.jpg){kind=link}